Chest wall reconstruction with implantable cross-linked porcine dermal collagen matrix: evaluation of clinical outcomes

HIGHLIGHTS

• who: Alessandro Gonfiotti MD PhD from the We evaluated the data in the database from the first case during October , through December, The use of the biological tissue matrix was approved by the clinical directorates of the involved institutes. Indications for using biological mesh and including patients in the database were: CWR in oncology patients, CWR after trauma, CWR in lung hernia, and CWR after resections for infectious disease. When its potential use was considered in the preoperative planning, patients were advised, and informed consents were obtained have published the research: Chest wall reconstruction with implantable cross . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.